0000950123-23-008186.txt : 20230814 0000950123-23-008186.hdr.sgml : 20230814 20230814163115 ACCESSION NUMBER: 0000950123-23-008186 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BC SW, LP CENTRAL INDEX KEY: 0001786351 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-20270 FILM NUMBER: 231171025 BUSINESS ADDRESS: STREET 1: 200 CLAREDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml X0202 13F-NT LIVE 0001786351 XXXXXXXX 06-30-2023 06-30-2023 false BC SW, LP

200 Clarendon Street Boston MA 02116

13F NOTICE 028-20270 28-18477 Bain Capital Life Sciences Investors, LLC Y The report on Form 13F for the period ended June 30, 2023 for BC SW, LP ("BC SW") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of BC SW. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 08-14-2023